Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CRL | ESRX | Q | ICLR | PRAH |
| Company | Charles River Laboratories Intl | Express Scripts | Quintiles Transitional Holdings | Icon Plc | Pra Health |
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 234.40 | 95.57 | 102.58 | 296.90 | 167.73 |
| High | 234.40 | 95.87 | 103.66 | 296.93 | 168.76 |
| Low | 229.85 | 92.11 | 101.62 | 290.63 | 164.28 |
| Last | 230.09 | 92.33 | 103.48 | 292.02 | 165.21 |
| Change | -2.25 | -3.47 | +0.57 | -2.01 | -2.80 |
| % Change | -0.97% | -3.62% | +0.55% | -0.68% | -1.67% |
| Volume | 499,800 | 31,612,900 | 1,299,700 | 386,200 | 13,411,000 |
| 20-Day Average Volume | 433,055 | 6,962,090 | 1,616,590 | 428,555 | 1,559,430 |
| Previous Close | 232.34 | 95.80 | 102.91 | 294.03 | 168.01 |
| Industry | Medical Services | Medical Services | Medical Services | Medical Services | Medical Services |
| Has Options | Yes | No | No | Yes | No |
| Technicals | |||||
| 20-Day Moving Average | 256.24 | 97.71 | 104.97 | 319.69 | 168.38 |
| 20-Day Raw Stochastic | 0.53% | 2.29% | 34.64% | 2.85% | 13.70% |
| 20-Day Relative Strength | 35.68% | 39.71% | 54.89% | 35.62% | 44.32% |
| Weighted Alpha | +14.48 | +35.70 | +34.10 | +35.81 | +71.79 |
| Today's Opinion | 40% Buy | N/A | N/A | 40% Buy | 40% Buy |
| Previous Opinion | 40% Buy | N/A | N/A | 56% Buy | 40% Buy |
| Last Month's Opinion | 100% Buy | N/A | N/A | 100% Buy | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.03% since 04/10/24 | -6.69% since 12/13/18 | -4.35% since 11/07/17 | -6.56% since 04/10/24 | -0.81% since 06/23/21 |
| Low | 229.85 on 04/17/24 | 92.11 on 12/20/18 | 101.18 on 11/13/17 | 290.63 on 04/17/24 | 164.28 on 06/30/21 |
| High | 250.72 on 04/11/24 | 99.98 on 12/14/18 | 108.82 on 11/08/17 | 314.31 on 04/11/24 | 170.82 on 06/28/21 |
| 1-Month | |||||
| %Chg | -11.15% since 03/15/24 | -3.11% since 11/20/18 | +3.64% since 10/13/17 | -12.77% since 03/15/24 | -3.34% since 05/28/21 |
| Low | 229.85 on 04/17/24 | 92.11 on 12/20/18 | 99.03 on 10/16/17 | 290.63 on 04/17/24 | 164.28 on 06/30/21 |
| High | 274.77 on 03/22/24 | 101.73 on 12/03/18 | 110.67 on 11/07/17 | 339.45 on 03/21/24 | 172.43 on 06/01/21 |
| 3-Month | |||||
| %Chg | +13.06% since 01/17/24 | -2.85% since 09/20/18 | +14.99% since 08/14/17 | +17.83% since 01/17/24 | +7.45% since 03/30/21 |
| Low | 201.27 on 01/18/24 | 91.92 on 10/24/18 | 89.76 on 08/15/17 | 244.78 on 01/18/24 | 151.77 on 04/01/21 |
| High | 275.00 on 03/08/24 | 101.73 on 12/03/18 | 110.67 on 11/07/17 | 344.77 on 03/06/24 | 175.95 on 05/25/21 |
| 6-Month | |||||
| %Chg | +19.87% since 10/17/23 | +15.27% since 06/20/18 | +24.84% since 05/12/17 | +22.97% since 10/17/23 | +33.13% since 12/30/20 |
| Low | 161.65 on 11/01/23 | 72.00 on 08/01/18 | 81.74 on 05/17/17 | 221.20 on 10/20/23 | 119.90 on 02/08/21 |
| High | 275.00 on 03/08/24 | 101.73 on 12/03/18 | 110.67 on 11/07/17 | 344.77 on 03/06/24 | 175.95 on 05/25/21 |
| Key Statistics | |||||
| Market Capitalization, $K | 11,968,066 | 52,061,192 | 21,866,360 | 24,256,004 | 10,704,781 |
| Shares Outstanding, K | 51,511 | 563,860 | 211,310 | 82,495 | 64,795 |
| Annual Sales | 4,129,410,000 | 100,064,600,000 | 6,878,000,000 | 8,120,180,000 | 3,183,370,000 |
| Annual Net Income | 474,620,000 | 4,517,400,000 | 115,000,000 | 612,340,000 | 197,040,000 |
| Last Quarter Sales | 1,013,480,000 | 25,563,200,000 | 2,465,000,000 | 2,066,250,000 | 933,780,000 |
| Last Quarter Net Income | 187,080,000 | 1,071,600,000 | 84,000,000 | 216,420,000 | 56,940,000 |
| 60-Month Beta | 1.40 | 0.88 | 0.65 | 1.15 | 1.33 |
| Per-Share Information | |||||
| Most Recent Earnings | 2.46 on 02/14/24 | 2.43 on 10/31/18 | 1.19 on 10/26/17 | 3.46 on 02/21/24 | 1.35 on 04/28/21 |
| Latest Earnings Date | 05/09/24 | 10/31/18 | 10/26/17 | 04/24/24 | 08/05/21 |
| Most Recent Dividend | N/A | N/A | N/A | N/A | N/A |
| Next Ex-Dividends Date | N/A | N/A | N/A | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 22.15 | 11.17 | 23.50 | 24.34 | 38.71 |